Nineteen new halogenated diarylpyridinamine (DAPA) analogues (6a-n and 8a-e) modified on the phenoxy C-ring were synthesized and evaluated for anti-HIV activity and certain drug-like properties. Ten compounds showed high anti-HIV activity (EC50 0.3, LLE >5, LELP <10). With balanced potency and drug-like properties, 8c merits further development as an anti-HIV drug candidate
A series of new diarylpyrimidines (DAPYs) characterized by a halogen atom on the methylene linker be...
30 new analogues of diarylpyrimidines were synthesized for further structural modifications, involvi...
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Severa...
Nineteen new halogenated diarylpyridinamine (DAPA) analogues (6a-n and 8a-e) modified on the phenoxy...
Using physicochemical property-driven optimization, twelve new diarylaniline compounds (DAANs) (7a–h...
As a continuation of our efforts to discover and develop "me-better" drugs of DAPYs, novel diarylpyr...
Based on the structures and activities of our previously identified non-nucleoside reverse transcrip...
The current optimization of 2,4-diarylaniline analogs (DAANs) on the central phenyl ring provided a ...
Three series (6, 13, and 14) of new diarylaniline (DAAN) analogues were designed, synthesized, and e...
Twenty-one new 4-substituted diarylaniline compounds (DAANs) (Scheme 2, series 13, 14, and 15) were ...
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies, a series of no...
Two series (4 and 5) of diarylpyridine derivatives were designed, synthesized, and evaluated for ant...
The development of novel NNRTIs with activity against variants of HIV-1RT is crucial for overcoming ...
To improve the conformational flexibility and positional adaptability of the traditional diarylpyrim...
Based on the crystallographic studies of diarylpyrimidines (DAPYs), we embarked on incorporating the...
A series of new diarylpyrimidines (DAPYs) characterized by a halogen atom on the methylene linker be...
30 new analogues of diarylpyrimidines were synthesized for further structural modifications, involvi...
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Severa...
Nineteen new halogenated diarylpyridinamine (DAPA) analogues (6a-n and 8a-e) modified on the phenoxy...
Using physicochemical property-driven optimization, twelve new diarylaniline compounds (DAANs) (7a–h...
As a continuation of our efforts to discover and develop "me-better" drugs of DAPYs, novel diarylpyr...
Based on the structures and activities of our previously identified non-nucleoside reverse transcrip...
The current optimization of 2,4-diarylaniline analogs (DAANs) on the central phenyl ring provided a ...
Three series (6, 13, and 14) of new diarylaniline (DAAN) analogues were designed, synthesized, and e...
Twenty-one new 4-substituted diarylaniline compounds (DAANs) (Scheme 2, series 13, 14, and 15) were ...
Guided by crystal structures of HIV-1 RT/DAPY complex and molecular modeling studies, a series of no...
Two series (4 and 5) of diarylpyridine derivatives were designed, synthesized, and evaluated for ant...
The development of novel NNRTIs with activity against variants of HIV-1RT is crucial for overcoming ...
To improve the conformational flexibility and positional adaptability of the traditional diarylpyrim...
Based on the crystallographic studies of diarylpyrimidines (DAPYs), we embarked on incorporating the...
A series of new diarylpyrimidines (DAPYs) characterized by a halogen atom on the methylene linker be...
30 new analogues of diarylpyrimidines were synthesized for further structural modifications, involvi...
The synthesis and anti-HIV-1 activity of a series of diarylpyrimidines (DAPYs) are described. Severa...